Accelerating and de-risking discovery of de novo cyclic peptides and microproteins

New drug modalities are needed to solve pressing medical problems. Cyclic peptides and microproteins show great promise and can be discovered by screening huge peptide libraires and machine learning-assisted microprotein design, respectively. We will use state-of-the-art instrumentation to allow us to find better molecules, faster.